Startseite>>Signaling Pathways>> Metabolism>> Ferroptosis>>ML-162

ML-162

Katalog-Nr.GC44214

ML-162 ist ein kovalenter Glutathionperoxidase 4 (GPX4)-Inhibitor. ML-162 hat eine selektive tödliche Wirkung auf mutierte RAS-Onkogen-exprimierende Zelllinien

Products are for research use only. Not for human use. We do not sell to patients.

ML-162 Chemische Struktur

Cas No.: 1035072-16-2

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
85,00 $
Auf Lager
10 mM * 1 mL in DMSO
85,00 $
Auf Lager
5mg
77,00 $
Auf Lager
10mg
119,00 $
Auf Lager
25mg
252,00 $
Auf Lager
50mg
406,00 $
Auf Lager
100mg
651,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com


Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

ML-162 is a GPX4 inhibitor that is selectively lethal to mutant RAS oncogene-expressing cell lines (IC50s = 25 and 578 nM for HRASG12V-expressing and wild-type BJ fibroblasts, respectively).[1],[2] It shares a similar structure but is more potent and selective than (1S,3R)-RSL3, a previously reported inhibitor of RAS oncogene-expressing cells.[2]

Reference:
[1]. Yang, W.S., and Stockwell, B.R. Ferroptosis: Death by lipid peroxidation. Trends Cell Biol. 26(3), 165-176 (2016).
[2]. Weïwer, M., Bittker, J.A., Lewis, T.A., et al. Development of small-molecule probes that selectively kill cells induced to express mutant RAS. Bioorg. Med. Chem. Lett. 22(4), 1822-1826 (2012).

Bewertungen

Review for ML-162

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ML-162

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.